Department of Health Sciences and Technology & Institute of Molecular Systems Biology & BioMedical Proteomics Platform (BMPP), ETH Zurich, Zurich, Switzerland.
Merck Ventures B. V., Gustav Mahlerplein 102, 1082MA, Amsterdam, The Netherlands.
Nat Commun. 2018 Apr 17;9(1):1519. doi: 10.1038/s41467-018-03936-z.
Cellular responses depend on the interactions of extracellular ligands, such as nutrients, growth factors, or drugs, with specific cell-surface receptors. The sensitivity of these interactions to non-physiological conditions, however, makes them challenging to study using in vitro assays. Here we present HATRIC-based ligand receptor capture (HATRIC-LRC), a chemoproteomic technology that successfully identifies target receptors for orphan ligands on living cells ranging from small molecules to intact viruses. HATRIC-LRC combines a click chemistry-based, protein-centric workflow with a water-soluble catalyst to capture ligand-receptor interactions at physiological pH from as few as 1 million cells. We show HATRIC-LRC utility for general antibody target validation within the native nanoscale organization of the surfaceome, as well as receptor identification for a small molecule ligand. HATRIC-LRC further enables the identification of complex extracellular interactomes, such as the host receptor panel for influenza A virus (IAV), the causative agent of the common flu.
细胞反应取决于细胞外配体(如营养物、生长因子或药物)与特定细胞表面受体的相互作用。然而,这些相互作用对非生理条件的敏感性使得它们难以通过体外分析进行研究。在这里,我们提出了基于 HATRIC 的配体受体捕获(HATRIC-LRC),这是一种化学蛋白质组学技术,可成功鉴定从小分子到完整病毒的活细胞上孤儿配体的靶受体。HATRIC-LRC 将基于点击化学的、以蛋白质为中心的工作流程与水溶性催化剂结合使用,可在生理 pH 下从少至 100 万个细胞中捕获配体-受体相互作用。我们展示了 HATRIC-LRC 在表面组的天然纳米级组织内进行一般抗体靶标验证以及小分子配体的受体鉴定方面的实用性。HATRIC-LRC 还能够鉴定复杂的细胞外相互作用组,例如流感病毒(IAV)的宿主受体组,IAV 是普通流感的病原体。